Studies Probe Potential of Experimental Therapies for Alzheimer Disease

摘要

Chicago-Although efforts to develop treatments for Alzheimer disease have met limited success to date, some experts are heartened by new findings from studies of several experimental Alzheimer disease therapies. While the results, reported at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD), held here in July, were mixed and most of the particularly promising drugs will require additional study, researchers are optimistic that several agents may eventually change the landscape of Alzheimer disease treatment."We are making progress. It is very important that we have as many drugs as possible in the pipeline for Alzheimer's and that we explore every available avenue for treatment," said Ralph Nixon, MD, PhD, of the New York University School of Medicine in New York City and a member of the Alzheimer's Association's Medical and Scientific Advisory Council.